<SEC-DOCUMENT>0001104659-23-117180-index.html : 20231113 <SEC-HEADER>0001104659-23-117180.hdr.sgml : 20231113 <ACCEPTANCE-DATETIME>20231113155957 ACCESSION NUMBER: 0001104659-23-117180 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20231213 FILED AS OF DATE: 20231113 DATE AS OF CHANGE: 20231113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VYNE Therapeutics Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38356 FILM NUMBER: 231398362 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 N., SUITE 301 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 800-775-7936 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206 N., SUITE 301 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics Inc. DATE OF NAME CHANGE: 20180201 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics, Inc. DATE OF NAME CHANGE: 20170728 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14A <SEQUENCE>1 <FILENAME>tm2330482-1_def14a.htm <DESCRIPTION>DEF 14A <TEXT> Document 1 - file: tm2330482-1_def14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>lg_vynetherapeutics-4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: lg_vynetherapeutics-4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>sg_daviddonzalski-bwlr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: sg_daviddonzalski-bwlr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>px_23page01-bw.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: px_23page01-bw.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>px_23page02-bw.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: px_23page02-bw.jpg
</DOCUMENT> </SEC-DOCUMENT>